checkAd
    Startseite > Aktien > Microbot Medical > Nachrichten
    Microbot Medical Aktie
    0,9401
     
    USD
    -2,83 %
    -0,0274 USD
    Letzter Kurs 17.05.24 Nasdaq
    0,9400
     
    USD
    200 STK
    Geldkurs 17.05.24
    0,9500
     
    USD
    4.200 STK
    Briefkurs 17.05.24
    ISIN: US59503A2042 · WKN: A2N5AS · SYM: MBOT · USA

    Neueste Nachrichten

    Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health
    29.04.24 · globenewswire · Microbot Medical
    Microbot Medical Shares Status Following Recent Geopolitical Events
    15.04.24 · globenewswire · Microbot Medical
    Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
    05.02.24 · globenewswire · Microbot Medical
    Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
    30.01.24 · globenewswire · Microbot Medical
    Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study
    18.01.24 · globenewswire · Microbot Medical
    Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
    29.12.23 · globenewswire · Microbot Medical
    Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met
    28.12.23 · globenewswire · Microbot Medical
    Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities
    21.11.23 · globenewswire · Microbot Medical
    Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process
    13.11.23 · globenewswire · Microbot Medical
    Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office
    08.11.23 · globenewswire · Microbot Medical
    Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study
    31.10.23 · globenewswire · Microbot Medical
    Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024
    24.10.23 · globenewswire · Microbot Medical